Topic: regenerative medicine
BioCardia birngs on Mark Schwartz to be its vice president of clinical affairs as it moves forward with a phase 3 trial of its cell therapy.
United Therapeutics signed on to a collaboration with Israel-based CollPlant for the development of 3D-printed lung transplants.
An antisense technology for silencing genes that contribute to hampered insulin production may help treat Type 2 diabetes.
Researchers accidentally reprogrammed mature neurons into dopamine-producing neurons—a discovery that could spark new therapies for brain diseases.
A newly found stem cell can differentiate into just bone cells without the unwanted lineages found in previous cultures.
OxStem named Georg Terstappen chief scientific officer, to help lead its six programs aiming to stimulate stem-cell repair mechanisms in the body.
Implanted iPSC-derived, scaffold-based liver tissues produced promising results in mice with tyrosinemia.
Males of soybean cyst nematode, or H. glycines, are able reverse neurodegeneration as part of their natural life cycle.
After reprogramming a type of retinal cells, Mount Sinai scientists helped blind mice regain some visual function.
Pluristem and Thermo Fisher will collaborate to scale up manufacturing of regenerative medicines, to build an industry capable of millions of doses.